Harrow, Inc., formerly Harrow Health, Inc., is a eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides comprehensive portfolio of prescription and non-prescription pharmaceutical products. The Company offers pharmaceutical products for ophthalmic surgeries in the United States, as well as medications prescribed to treat patients managing chronic and acute eye conditions, such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions. It serves over 10,000 doctors, hospitals, and ambulatory service centers (ASCs) and regularly ship to over 1,500 institutional accounts each month.